ACERTA PHARMA BV PATENTS FACING OPPOSITIONS
Top patents of ACERTA PHARMA BV facing oppositions at the European Patent Office (EPO)
Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
EP3954690B1 |
05 Apr, 2023
|
Solid Forms And Formulations Of (S)-4-(8-Amino-3-(1-(But-2-Ynoyl)Pyrrolidin-2-Yl)Imidazo[1,5-A]Pyrazin-1-Yl)-N-(Pyridin-2-Yl)Benzamide
|
Jul, 2036
|
1
| |
EP3179991B1 |
06 Oct, 2021
|
Therapeutic Combinations Of A Btk Inhibitor, A Pi3K Inhibitor, A Jak-2 Inhibitor, And/Or A Bcl-2 Inhibitor
|
Aug, 2035
|
1
| |
EP3317281B1 |
22 Apr, 2020
|
Solid Forms And Formulations Of (S)-4-(8-Amino-3-(1 -(But-2-Ynoyl)Pyrrolidin-2-Yl)Imidazo[1,5-A]Pyrazin-1-Yl)-N-(Pyridin-2-Yl)Benzamide
|
Jul, 2036
|
1
| |